Inactive Instrument

Vical Incorporated Stock price Nasdaq

Equities

US9256022032

Biotechnology & Medical Research

Sales 2022 6.94M Sales 2023 8.01M Capitalization 5.25M
Net income 2022 -21M Net income 2023 -5M EV / Sales 2022 -0.59 x
Net cash position 2022 8.63M Net cash position 2023 10.87M EV / Sales 2023 -0.7 x
P/E ratio 2022
-0.2 x
P/E ratio 2023
-0.83 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 98.4%
More Fundamentals * Assessed data
Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 72 20-11-30
Chief Tech/Sci/R&D Officer - 15-12-31
Comptroller/Controller/Auditor - 20-06-30
Members of the board TitleAgeSince
Chief Executive Officer 72 20-11-30
More insiders
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.
More about the company